Are you healthy and looking to help advance medical science?

You may be eligible to participate in a chronic interstitial cystitis clinical study, and could be compensated for your time.

Are you healthy and looking to help advance medical science? You may be eligible to participate in a chronic interstitial cystitis clinical study, and could be compensated for your time.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Chronic Interstitial Cystitis Clinical Trial in Seoul

NCT02331472 | Observational patient registry

Are you healthy and looking to help advance medical science?

You may be eligible to participate in a chronic interstitial cystitis clinical study, and could be compensated for your time.

Are you healthy and looking to help advance medical science? You may be eligible to participate in a chronic interstitial cystitis clinical study, and could be compensated for your time.

Completed

Male & Female

20 Years +

This study has recruited 80 Participants

This study is to evaluate the efficacy of urine biomarker in patients with interstitial cystitis/painful bladder syndrome

Show me more details

Details for the study

Population

Interstitial cystitis

Brief Title

The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study)

Official Title

The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome

Brief Summary

This study is to evaluate the efficacy of urine biomarker in patients with interstitial<br /> cystitis/painful bladder syndrome

Outcome Measures

Outcome measures are the tests that investigators perform to prove whether or not a treatment being tested in a clinical trial is having any effect.

Primary

Difference of RNA expression of the urine biomarker between the interstitial cystitis and control groups

1day

Secondary

Difference of RNA expression of the urine biomarker between Hunner ulcer interstitial cystitis and non-ulcer interstitial cystitis groups

1day

Secondary

Difference of RNA expression of the urine biomarker in interstitial cystitis according to pain score on the visual analogue scale

1day

Study Criteria

Inclusion Criteria:

  1. must have experienced bladder pain, urinary urgency and frequency for at least 6
     months prior to entry into the study

  2. Pain VAS >4

  3. PUF score >13

  4. ICQ score >12

4) cystoscopic record within 2years

Exclusion Criteria:

  1. Patients who are pregnancy or, childbearing age without no contraception

  2. Patient with microscopic hematuria, if not excluded that no evidence of neoplastic
     tumor examination

  3. patients with urine culture showing evidence of urinary tract infection 1month prior
     to the study

  4. Accompanied medical problem below

       -  Tuberculosis in urinary system

       -  Bladder cancer, urethral cancer, Prostate cancer

       -  Recurrent cystitis

       -  Anatomical disorder

  5. Patients had prior surgery (bladder augmentation, cystectomy)

  6. Patients with neurologic disorder

  7. Patients with indwelling catheter or intermittent self-catheterization

  8. Patients with psychological problem